The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Open accessAbstract
Biofilm-related infections account for at least 65% of all human infections, but there are no available antimicrobials that specifically target biofilms. Their elimination by available treatments is inefficient since biofilm cells are between 10- and 1,000-fold more resistant to conventional antibiotics than planktonic cells. Here we describe the synergistic interactions, with different classes of antibiotics, of a recently characterized antibiofilm peptide, 1018, to potently prevent and eradicate bacterial biofilms formed by multidrug-resistant ESKAPE ( Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter species) pathogens. Combinations of peptide 1018 and the antibiotic ceftazidime, ciprofloxacin, imipenem, or tobramycin were synergistic in 50% of assessments and decreased by 2- to 64-fold the concentration of antibiotic required to treat biofilms formed by Pseudomonas aeruginosa , Escherichia coli , Acinetobacter baumannii , Klebsiella pneumoniae , Salmonella enterica , and methicillin-resistant Staphylococcus aureus . Furthermore, in flow cell biofilm studies, combinations of low, subinhibitory levels of the peptide (0.8 μg/ml) and ciprofloxacin (40 ng/ml) decreased dispersal and triggered cell death in mature P. aeruginosa biofilms. In addition, short-term treatments with the peptide in combination with ciprofloxacin prevented biofilm formation and reduced P. aeruginosa PA14 preexisting biofilms. PCR studies indicated that the peptide suppressed the expression of various antibiotic targets in biofilm cells. Thus, treatment with the peptide represents a novel strategy to potentiate antibiotic activity against biofilms formed by multidrug-resistant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Self-citationActive Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011) · Science · doi:10.1126/science.1211037 · Cited by 978
The clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
Biofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Self-citationColvin, K. M., Gordon, V. D., Murakami, K., Borlee, B. R., Wozniak, D. J., Wong, G. C. L., & Parsek, M. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001264 · Cited by 577
Biofilm formation and dispersal and the transmission of human pathogens
Hall-Stoodley, L., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.004 · Cited by 576
Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521
Self-citation
Cited by
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
Staphylococcus aureus biofilms: recent developments in biofilm dispersal
Lister, J. L., & Horswill, A. R. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00178 · Cited by 706
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Metadata
- Authors
- Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2014-09
- Volume
- 58
- Issue
- 9
- Pages
- 5363-5371
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2101217433
- Cited by
- 293
- References
- 22
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms. https://app.cochat.ai/papers/10.1128/aac.03163-14
- The paper
- Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014). A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.03163-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.